Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell transplant – a case series

References

• Elsner C, Dorries K. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology. 1992;191:72–80.
   PubMed Web of Science ®Google Scholar
• Major EO, Amemiya K, Tornatore CS, et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 1992;5:49–73.
   PubMed Web of Science ®Google Scholar
• Major EO. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med. 2010;61:35–47.
   PubMed Web of Science ®Google Scholar
• Focosi D, Marco T, Kast RE, et al. Progressive multifocal leukoencephalopathy: what’s new? Neuroscientist. 2010;16:308–323.
   PubMed Web of Science ®Google Scholar
• Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy. A hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain. 1958;81:93–111.
   PubMed Web of Science ®Google Scholar
• Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998. Neurology. 2001;56:257–260.
   PubMed Web of Science ®Google Scholar
• Garcia-Suarez J, de Miguel D, Krsnik I, et al. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies. Am J Hematol. 2005;80:271–281.
   PubMed Web of Science ®Google Scholar
• Wittmann T, Horowitz N, Benyamini N, et al. JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications. Bone Marrow Transplant. 2015;50:984–991.
   PubMed Web of Science ®Google Scholar
• Morrison VA. Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies. Clin Infect Dis. 2014;59:S360–S364.
   PubMed Web of Science ®Google Scholar
• Bohra C, Sokol L, Dalia S. Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. Cancer Control. 2017;24:1073274817729901.
   Web of Science ®Google Scholar
• Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009;113:4834–4840.
   PubMed Web of Science ®Google Scholar
• Mateen FJ, Muralidharan R, Carone M, et al. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol. 2011;70:305–322.
   PubMed Web of Science ®Google Scholar
• Amend KL, Turnbull B, Foskett N, et al. Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology. 2010;75:1326–1332.
   PubMed Web of Science ®Google Scholar
• Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum. 2009;60:3761–3765.
   PubMed Web of Science ®Google Scholar
• Neil EC, DeAngelis LM. Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review. Blood Adv. 2017;1:2041–2045.
   PubMed Web of Science ®Google Scholar
• Pruitt AA. CNS infections in patients with cancer. Continuum (Minneap Minn). 2012;18:384–405.
   PubMedGoogle Scholar
• Kalisch A, Wilhelm M, Erbguth F, et al. Progressive multifocal leukoencephalopathy in patients with a hematological malignancy: review of therapeutic options. Chemotherapy. 2014;60:47–53.
   PubMed Web of Science ®Google Scholar
• Tan CS, Broge TA, Jr., Ngo L, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation. Biol Blood Marrow Transplant. 2014;20:992–999.
   PubMed Web of Science ®Google Scholar
• Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9:425–437.
   PubMed Web of Science ®Google Scholar
• Hurley RA, Ernst T, Khalili K, et al. Identification of HIV-associated progressive multifocal leukoencephalopathy: magnetic resonance imaging. J Neuropsychiatry Clin Neurosci. 2003;15:1–6.
   PubMed Web of Science ®Google Scholar
• Ikeda J, Matsushima A, Ishii W, et al. Brain biopsy is more reliable than the DNA test for JC virus in cerebrospinal fluid for the diagnosis of progressive multifocal leukoencephalopathy. Intern Med. 2017;56:1231–1234.
   PubMed Web of Science ®Google Scholar
• Fong IW, Britton CB, Luinstra KE, et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol. 1995;33:484–486.
   PubMed Web of Science ®Google Scholar
• Bossolasco S, Calori G, Moretti F, et al. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis. 2005;40:738–744.
   PubMed Web of Science ®Google Scholar
• Giudici B, Vaz B, Bossolasco S, et al. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis. 2000;30:95–99.
   PubMed Web of Science ®Google Scholar
• Pavlovic D, Patera AC, Nyberg F, et al. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord. 2015;8:255–273.
   PubMed Web of Science ®Google Scholar
• De-Simone FI, Sariyer R, Otalora YL, et al. IFN-gamma inhibits jc virus replication in glial cells by suppressing T-antigen expression. PLoS One. 2015;10:e0129694.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Jaeckle KA, Birdwell RR, et al. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant. 1997;20:983–987.
   PubMed Web of Science ®Google Scholar
• Balduzzi A, Lucchini G, Hirsch HH, et al. Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient. Bone Marrow Transplant. 2011;46:987–992.
   PubMed Web of Science ®Google Scholar
• Sano Y, Nakano Y, Omoto M, et al. Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment. Intern Med. 2015;54:965–970.
   PubMed Web of Science ®Google Scholar
• Carson KR, Newsome SD, Kim EJ, et al. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. 2014;120:2464–2471.
   PubMed Web of Science ®Google Scholar